RT Book, Section A1 Damon, Lloyd E. A1 Andreadis, Charalambos Babis A2 Papadakis, Maxine A. A2 Rabow, Michael W. A2 McQuaid, Kenneth R. A2 Gandhi, Monica SR Print(0) ID 1209225383 T1 Sickle Cell Anemia & Related Syndromes T2 Current Medical Diagnosis & Treatment 2025 YR 2025 FD 2025 PB McGraw-Hill Education PP New York, NY SN 9781266266232 LK accessmedicine.mhmedical.com/content.aspx?aid=1209225383 RD 2024/11/04 AB Key Clinical Updates in Sickle Cell Anemia & Related SyndromesTwo genetically engineered stem cell products used with autologous transplantation, lovotibeglogene autotemcel and exagamglogene autotemcel, are approved in the United States for patients 12 years or older with severe disease and offer the potential for long-term disease control.Kanter J et al. N Engl J Med. [PMID: 34898139]